Clicky

Illumina, Inc.(ILMN)

Description: Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for the analysis of genetic variation and biological function in North America, Europe, Latin America, the Asia-Pacific, the Middle East, and South Africa. Its sequencing platforms include HiSeq 2000, an instrument for high-throughput sequencing using sequencing by synthesis (SBS) technology; HiSeq 1500 that accommodates lower throughput needs; and MiSeq Personal Sequencing System that offers sequencing applications in a compact and economical instrument for individual researchers. The company's sequencing/array combination platforms comprise HiScanSQ that combines SBS technology and HiScan microarray analysis instrumentation into one system. Its array platforms consist of HiScan and iScan systems that are array scanners, which support the imaging of its array-based genetic analysis products. The company also offers various sample preparation and sequencing kits, such as standard sequencing kits; Infinium assay kits; paired-end genomic deoxyribonucleic acid (DNA) sample prep kits; and TruSeq SBS sequencing kits, as well as library preparation kits. In addition, it provides InfiniumHD Whole-Genome BeadChips, which are multi-sample DNA analysis microarrays; HumanOmni5-Quad, HumanOmni2.5, and HumanOmni1S BeadChips; agriculturally relevant genome panels; and iSelect Custom Genotyping BeadChips. Further, it offers CytoChip, a test for the investigation of genetic abnormalities associated with developmental delay or with complex leukemia's; Eco Real-Time polymerase chain reaction system; and sequencing and genotyping services. The company serves genomic research centers, academic institutions, government laboratories, and clinical research organizations, as well as pharmaceutical, biotechnology, agri-genomics, and consumer genomics companies. It sells its products directly and through distributors. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.


Keywords: Biotechnology Life Sciences S&P 500 Biology Imaging Nasdaq 100 Telemedicine Telehealth Molecular Biology Acid Genomics Clinical Research Scanner Lab Testing Polymerase Chain Reaction DNA Sequencing Genome Genotyping DNA Chip Exome Sequencing Life Science Tools Markets Life Science Tools

Home Page: www.illumina.com

ILMN Technical Analysis

5200 Illumina Way
San Diego, CA 92122
United States
Phone: 858 202 4500


Officers

Name Title
Mr. Francis A. deSouza CEO & Director
Dr. Alexander Aravanis M.D., Ph.D. CTO & Head of Research and Product Devel.
Mr. Charles E. Dadswell Sr. VP, Gen. Counsel & Sec.
Ms. Susan H. Tousi Chief Commercial Officer
Stephanie Campos Pres
Dr. Joydeep Goswami M.B.A., Ph.D. Chief Strategy & Corp. Devel. Officer and Interim CFO
Mr. Kevin Carl Pegels Chief of Global Operations
Mr. Scott Ericksen VP & Chief Accounting Officer
Ms. Carissa Rollins Chief Information Officer
Ms. Sallilyn Schwartz VP of Investor Relations

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 72.9927
Trailing PE: 46.6914
Price-to-Book MRQ: 4.9071
Price-to-Sales TTM: 6.9433
IPO Date: 2000-07-28
Fiscal Year End: December
Full Time Employees: 9800
Back to stocks